CLINICAL_TRIALS
trial_result
· 2020-12-16
Clinical Trial Update: A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA) [Phase 2]
Summary
Phase 2 trial of ruxolitinib phosphate cream for alopecia areata was terminated; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Incyte Corporation | Conditions: Alopecia Areata | Phase 2 | Status: TERMINATED | Results posted: 2020-12-16